Quick Answer
BIOFORCE NANOSCIENCES HOLDINGS, INC. reported Stockholders Equity of -$2.30 million for the year ending 2024.
- BIOFORCE NANOSCIENCES HOLDINGS, INC. showed a decrease of -26.5% in Stockholders Equity from 2023 to 2024.
- This data is from BIOFORCE NANOSCIENCES HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $14.1 thousand | Q2 2018: $16.3 thousand | Q3 2018: $23.9 thousand | Q1 2019: $34.2 thousand | Q2 2019: $41.9 thousand | Q3 2019: $48.4 thousand | Q1 2020: $7.3 thousand | Q2 2020: -$119.4 thousand | Q3 2020: -$237.3 thousand | Q1 2021: -$505.0 thousand | Q2 2021: -$627.3 thousand | Q3 2021: -$741.2 thousand | Q1 2022: -$994.3 thousand | Q2 2022: -$1.11 million | Q3 2022: -$1.23 million | Q1 2023: -$1.48 million | Q2 2023: -$1.59 million | Q3 2023: -$1.70 million | Q4 2023: -$1.82 million | Q1 2024: -$1.95 million | Q2 2024: -$2.06 million | Q3 2024: -$2.18 million | Q4 2024: -$2.30 million | Q1 2025: -$261.2 thousand | Q2 2025: -$384.0 thousand | Q3 2025: -$499.9 thousand.
- Over the full 9 years of available data (2016 to 2024), BIOFORCE NANOSCIENCES HOLDINGS, INC.'s Stockholders Equity has declined by 100,826.1%.
- Historical annual values: Fiscal year 2024: -$2.30 million | Fiscal year 2023: -$1.82 million | Fiscal year 2022: -$1.35 million | Fiscal year 2021: -$861.9 thousand | Fiscal year 2020: -$359.9 thousand | Fiscal year 2019: $47.3 thousand | Fiscal year 2018: $29.8 thousand | Fiscal year 2017: $8.2 thousand | Fiscal year 2016: $2.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: